Polycythemia Vera Treatments Potentially Not Being Used to Their Full Advantage
Drug Topics
MAY 18, 2023
Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.
Drug Topics
MAY 18, 2023
Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options.
PharmaVoice
MAY 18, 2023
Pending Senate confirmation, NCI head Monica Bertagnolli will take the helm of the collection of research organizations as it faces increasing bipartisan scrutiny.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 18, 2023
Health plans must continue providing free screenings pending court’s further consideration of case.
PharmaVoice
MAY 18, 2023
Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MAY 18, 2023
Improving awareness and getting involved in local or national initiatives can enable pharmacists to make change.
Drug Store News
MAY 18, 2023
In a statement, Walgreens said it "disputes liability" and did not admit fault, but settling allows it to focus on patients, customers and communities.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
MAY 18, 2023
Unions ask DOJ to investigate UPMC for alleged anticompetitive worker suppression dmuoio Thu, 05/18/2023 - 10:20
Pharmacy Times
MAY 18, 2023
As demand increases, pharmacies can diversify by offering brain-function assessments to patients.
Fierce Pharma
MAY 18, 2023
Teva's new CEO Francis lays out his 'pivot to growth' strategy kdunleavy Thu, 05/18/2023 - 11:24
Pharmacy Times
MAY 18, 2023
In clinical trials of patients with Crohn disease, upadacitinib demonstrated early and long-term symptom relief, as well a visible reduction of damage to the intestinal lining caused by excess inflammation.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 18, 2023
A committee of vaccine experts voted to recommend the Food and Drug Administration approve Pfizer’s maternal RSV vaccine on Thursday, though the panel expressed some safety concerns. The Vaccines and Related Biological Products Advisory Committee voted 14-0 that Pfizer’s data showed the vaccine was effective in preventing severe disease in infants born to people who were vaccinated during pregnancy.
Drug Store News
MAY 18, 2023
Lash Blast Cleantopia is a clean and vegan mascara that offers extreme lash volume, the company said.
STAT
MAY 18, 2023
This legislative session, Gov. Bill Lee made history by signing a bill that makes Tennessee the first state in the country to remove redundant medical-residency requirements for top international doctors. By opening a new pathway for doctors trained outside the United States, HB1312 and SB1451 , introduced by state Rep. Sabi Kumar and state Sen. Kerry Roberts, will help Tennessee address its growing physician shortage.
Pharmaceutical Technology
MAY 18, 2023
The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. Within the 14-page document , published by an EMA special task force, are 10 recommendations of best practices that “marketing authorisation holders, wholesalers, distributors, and manufacturers can consider adopting to ensure continuity of medicinal product supply and reduce the impact of shortages”.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MAY 18, 2023
The largest organ in the body is a wonder. Skin is soft, flexible, and sensitive to every imaginable stimuli, and seamlessly plugs into the nervous system. This makes it extremely difficult to replicate — but that hasn’t stopped a team of Stanford researchers from trying. “We hope in the future, prosthetic devices can not only give the functionality but also the appearance of our natural body,” said Weichen Wang, an engineering Ph.D. and first author on a paper on ele
Fierce Pharma
MAY 18, 2023
AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease kdunleavy Thu, 05/18/2023 - 15:54
STAT
MAY 18, 2023
As the deans of the two public medical schools in Nevada, we are watching with pride as our recent graduates prepare to start their internships. But that pride is tempered by concern about a looming threat to the delivery of medical care in our state.
Fierce Healthcare
MAY 18, 2023
A key House panel approved a slew of health policies.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 18, 2023
WASHINGTON — The federal government is aggressively exploring ways to increase access to methadone, a key Biden administration official told STAT. Methadone, a common addiction medication, is the most effective drug currently used to treat opioid use disorder. But it is only available in the context of specialized methadone clinics, making it nearly impossible for many patients to obtain.
The Checkup by Singlecare
MAY 18, 2023
If you have stubborn hay fever or seasonal allergies that aren’t responsive to other over-the-counter antihistamines, you may find success with Zyrtec. Along with Xyzal ( levocetirizine ), it is the most powerful OTC antihistamine allergy medication available. The drug works effectively against allergy symptoms like itchy or watery eyes, sneezing, a runny nose, and an itchy nose or throat.
STAT
MAY 18, 2023
A recent study by the Association of American Medical Colleges projects a shortage of between 17,800 and 48,000 primary care physicians by 2034. A December 2021 survey found that one in three physicians and advanced practice registered nurses intends to reduce their work hours, and one in five physicians plans to retire. By sheer number, the shortage is projected to be the worst in California, Texas, and Florida.
Fierce Healthcare
MAY 18, 2023
Government stats show number of uninsured declined in 2022, though experts question methodology, conclusion fdiamond Thu, 05/18/2023 - 15:06
The Checkup by Singlecare
MAY 18, 2023
The U.S. Food and Drug Administration (FDA) recently approved the oral medication Veozah (fezolinetant) for the treatment of moderate to severe hot flashes caused by menopause. Manufactured by Astellas Pharma, Veozah is the first neurokinin 3 (NK3) receptor antagonist to receive approval for the treatment of vasomotor symptoms (hot flashes). Hot flashes are very common among people going through menopause.
STAT
MAY 18, 2023
There is, according to Wall Street, no worse investment in biotech than Galapagos NV. The Belgian company trades at an enterprise value approaching negative $2 billion. That means its liquid assets, mostly cash, are worth more than the company itself. It means, according to the market, that every dollar Galapagos puts toward inventing new drugs would be better spent doing pretty much anything else.
pharmaphorum
MAY 18, 2023
Servier doubles up on ‘digital twin’ alliance with Aitia Phil.
STAT
MAY 18, 2023
In a case that had the pharmaceutical industry on edge, the U.S. Supreme Court upheld a lower court ruling that Amgen failed to disclose sufficient information about patent claims for a best-selling drug. The court ruled unanimously that Amgen failed to provide what amounts to a roadmap for others to recreate the claims made in two patents for Repatha, a cholesterol medication.
European Pharmaceutical Review
MAY 18, 2023
A new document published by European Medicines Agency (EMA) makes ten recommendations and outlines good practices “to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact.” Medicine shortages are a global health problem and are increasingly affecting European countries, according to EMA. Shortages can lead to medicine rationing, delay in critical treatments and can mean patients may need to use less-effective alternatives and face an increased risk of me
Drug Store News
MAY 18, 2023
Wakefern is placing Freeosk units in 95 ShopRite and The Fresh Grocer stores.
pharmaphorum
MAY 18, 2023
Innovation and development of generic pharmaceuticals Mike.
Drug Store News
MAY 18, 2023
The Gold Emblem refillable purified water is 100% recyclable, BPA-free and made from 68% recycled aluminum material.
pharmaphorum
MAY 18, 2023
A closer look at gene therapy with PTC Therapeutics Mike.
Drug Store News
MAY 18, 2023
The new caramel candy brand joins the growing MAI brand portfolio.
European Pharmaceutical Review
MAY 18, 2023
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending AbbVie’s upadacitinib (Rinvoq ® ) as an option for treating moderately to severely active Crohn’s disease in adults. The therapy is the first janus kinase (JAK) inhibitor that will be available for treatment of Crohn’s disease in England and Wales, AbbVie said.
Let's personalize your content